Summary Within a double-blind, cross-around trial, triazolam (0.twenty five mg) was analyzed towards flunitrazepam (one mg) in the typical midwinter sleeplessness that is frequently noticed amid otherwise healthy persons in Northern Norway. Each individual drug was offered for five nights, in random get, with a five-evening placebo period among the